Jaguar Health Jumps 304% as Vogenx Drops 12.65% in Tuesday Session
Jaguar Health surged over 300 percent while Vogenx fell 12.65 percent during Tuesday's trading, highlighting extreme volatility in the healthcare sector.
Key points
- Jaguar Health shares surged 304.5% to $10.80, driving a 300% increase in value for its $1.1 million market cap.
- Vogenx fell 12.65% to $25.77, marking the largest price decline among the top 12 moving healthcare stocks.
- Greenland Mines and Filana Therapeutics rose 72% and 48% respectively, while Silexion Therapeutics dropped 36%.
Jaguar Health (NASDAQ:JAGX) led Tuesday's healthcare moves, closing at $10.80 after a 304.5% spike. The small-cap firm, with a market capitalization of $1.1 million, saw its share price more than quadruple during the regular session, outpacing all other listed peers.
On the downside, Vogenx (NASDAQ:VOGX) slid 12.65% to $25.77. The company, valued at $438.2 million, was the most expensive stock in the group to decline, marking a significant intraday loss relative to its peers. These moves were reported by Benzinga in its intraday market data.
Small-Cap Names Drive Gains
Greenland Mines (NASDAQ:GRML) rose 72.18% to $16.22, reflecting a $29.9 million market value. Filana Therapeutics (NASDAQ:FLNA) followed with a 48.07% increase to $1.09, maintaining a $35.7 million valuation. Decoy Therapeutics (NASDAQ:DCOY) climbed 35.16% to $3.46, though its market cap remained minimal at $1.6 million.
Viking Therapeutics (NASDAQ:VKTX) gained 31.51% to reach $39.60. Unlike the smaller firms, Viking commands a $3.5 billion market capitalization, making its 31% move a substantial value shift. IM Cannabis (NASDAQ:IMCC) also advanced 27.84% to $3.94, with a market cap of $1.8 million.
Broad Sector Declines
Silexion Therapeutics (NASDAQ:SLXN) suffered the steepest drop, falling 36.1% to $0.35. The company’s market capitalization stands at $3.0 million. Compass Therapeutics (NASDAQ:CMPX) declined 26.65% to $1.33, representing a $327.7 million market value.
Xenetic Biosciences (NASDAQ:XBIO) lost 16.39% of its value, closing at $2.50 with a $7.0 million valuation. Gelteq (NASDAQ:GELS) dropped 15.83% to $0.48, while Enlivex (NASDAQ:ENLV) fell 13.36% to $0.60. Enlivex’s market cap is $12.1 million, indicating moderate liquidity for its price action.
Market Volatility Patterns
The disparity between the 304.5% gain in Jaguar Health and the 36.1% loss in Silexion Therapeutics underscores the high volatility typical of small-cap healthcare stocks. While Viking Therapeutics provided stability with its larger market cap, most other movers had valuations under $50 million. This session highlights how minor trading volumes can cause extreme price swings in lower-liquidity names.
